Healthcare provider profile · identity verified

Benjamin Philip Krage, D.O.

Family Practice · COON RAPIDS, MN · NPI 1609219252

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	515	132
Rosuvastatin Calcium	Rosuvastatin Calcium	387	115
Lisinopril	Lisinopril	320	80
Amlodipine Besylate	Amlodipine Besylate	257	74
Losartan Potassium	Losartan Potassium	229	63
Levothyroxine Sodium	Levothyroxine Sodium	227	60
Omeprazole	Omeprazole	207	53
Metformin Hcl Er	Metformin Hcl	199	50
Tamsulosin Hcl	Tamsulosin Hcl	186	59
Metoprolol Succinate	Metoprolol Succinate	165	51
Simvastatin	Simvastatin	127	36
Metformin Hcl	Metformin Hcl	126	40
Furosemide	Furosemide	116	36
Gabapentin	Gabapentin	109	38
Hydrochlorothiazide	Hydrochlorothiazide	108	34
Albuterol Sulfate Hfa	Albuterol Sulfate	102	41
Pantoprazole Sodium	Pantoprazole Sodium	100	27
Carvedilol	Carvedilol	99	24
Escitalopram Oxalate	Escitalopram Oxalate	93	30
Eliquis	Apixaban	92	22
Jardiance	Empagliflozin	87	17
Fluticasone Propionate	Fluticasone Propionate	86	38
Ozempic	Semaglutide	86	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	23
Warfarin Sodium	Warfarin Sodium	82	21
Allopurinol	Allopurinol	78	20
Chlorthalidone	Chlorthalidone	75	19
Trazodone Hcl	Trazodone Hcl	74	27
Atenolol	Atenolol	72	17
Famotidine	Famotidine	69	20
Glimepiride	Glimepiride	67	19
Metoprolol Tartrate	Metoprolol Tartrate	64	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	17
Tramadol Hcl	Tramadol Hcl	59	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	59	13
Triamcinolone Acetonide	Triamcinolone Acetonide	55	30
Glipizide	Glipizide	54	14
Prednisone	Prednisone	53	41
Clonazepam	Clonazepam	48	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Xarelto	Rivaroxaban	48	14
Doxycycline Hyclate	Doxycycline Hyclate	44	32
Potassium Chloride	Potassium Chloride	44	17
Sertraline Hcl	Sertraline Hcl	44	12
Citalopram Hbr	Citalopram Hydrobromide	42	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	11
Bupropion Xl	Bupropion Hcl	40	14
Duloxetine Hcl	Duloxetine Hcl	40	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	40	12
Montelukast Sodium	Montelukast Sodium	40	14
Pravastatin Sodium	Pravastatin Sodium	40	11
Mirtazapine	Mirtazapine	38	15
Propranolol Hcl Er	Propranolol Hcl	38	11
Finasteride	Finasteride	37	11
Terazosin Hcl	Terazosin Hcl	37	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	35	13
Celecoxib	Celecoxib	34	suppressed
Alprazolam	Alprazolam	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	12
Clopidogrel	Clopidogrel Bisulfate	32	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Trulicity	Dulaglutide	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	13
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Desonide	Desonide	24	suppressed
Glipizide Er	Glipizide	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Methylprednisolone	Methylprednisolone	23	21
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Naproxen	Naproxen	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	12
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Nystatin	Nystatin	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Prazosin Hcl	Prazosin Hcl	18	suppressed
Colchicine	Colchicine	17	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Azithromycin	Azithromycin	15	11
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Risperidone	Risperidone	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Cephalexin	Cephalexin	14	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Adderall Xr	Dextroamphetamine/Amphetamine	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Klor-Con	Potassium Chloride	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error